TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome

Laura Stanbery, Daniel Craig, Lauren Rager, Susan Morand, Alexander Nemunaitis, Natalie Nemunaitis, Jaxon Nejedlik, Jae Choi, Richard C. Phinney, John Nemunaitis

Open source

DOI
10.1080/14737140.2026.2756200
Published
2026-11-04
Container
Expert Review of Anticancer Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737140.2026.2756200,
  title = {TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome},
  author = {Laura Stanbery and Daniel Craig and Lauren Rager and Susan Morand and Alexander Nemunaitis and Natalie Nemunaitis and Jaxon Nejedlik and Jae Choi and Richard C. Phinney and John Nemunaitis},
  year = {2026},
  journal = {Expert Review of Anticancer Therapy},
  doi = {10.1080/14737140.2026.2756200},
  url = {https://doi.org/10.1080/14737140.2026.2756200}
}

RIS

TY  - JOUR
TI  - TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome
AU  - Laura Stanbery
AU  - Daniel Craig
AU  - Lauren Rager
AU  - Susan Morand
AU  - Alexander Nemunaitis
AU  - Natalie Nemunaitis
AU  - Jaxon Nejedlik
AU  - Jae Choi
AU  - Richard C. Phinney
AU  - John Nemunaitis
PY  - 2026
JO  - Expert Review of Anticancer Therapy
DO  - 10.1080/14737140.2026.2756200
UR  - https://doi.org/10.1080/14737140.2026.2756200
ER  - 

APA

Stanbery, L., Craig, D., Rager, L., Morand, S., Nemunaitis, A., Nemunaitis, N., Nejedlik, J., Choi, J., Phinney, R. C., & Nemunaitis, J. (2026). TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome. Expert Review of Anticancer Therapy. https://doi.org/10.1080/14737140.2026.2756200

Source records